Pubblicazioni

Exploring genetic factors involved in huntington disease age of onset. E2F2 as a new potential modifier gene

2015 - PLOS ONE

ValcÃ¡rcel Ocete, Leire; Alkorta Aranburu, Gorka; Iriondo, Mikel; Fullaondo, Asier; GarcÃa Barcina, MarÃa; FernÃ¡ndez GarcÃa, JosÃ© Manuel; Lezcano GarcÃa, Elena; Losada Domingo, JosÃ©marÃa; Ruiz Ojeda, Javier; De Arcaya, Amaia Ãlvarez; PÃ©rez Ramos, JosÃ© MarÃa; Roos, Raymund A. C.; Nielsen, JÃ¸rgen E.; Saft, Carsten; Registry, investigators of the European Huntington's Disease Network; Romano, Silvia; Zubiaga, Ana M.; Aguirre, Ana

The role of tau in the pathological process and clinical expression of Huntington's disease

2015 - BRAIN

Vuono, Romina; Winder Rhodes, Sophie; De Silva, Rohan; Cisbani, Giulia; Drouin Ouellet, Janelle; Registry, Investigators of the European Huntingtonâs Disease Network; Romano, Silvia; Spillantini, Maria G.; Cicchetti, Francesca; Barker, Roger A.

Antidopaminergic Medication is Associated with More Rapidly Progressive Huntington's Disease

2015 - JOURNAL OF HUNTINGTON'S DISEASE

Tedroff, Joakim; Waters, Susanna; Barker, Roger A.; Roos, Raymund; Squitieri, Ferdinando; EHDN Registry Study, Group; Romano, Silvia